Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by enriquesuaveon May 03, 2024 3:34pm
116 Views
Post# 36022358

RE:RE:CGON 35% 12 months CR?

RE:RE:CGON 35% 12 months CR?

Nice find!  We are killing them in our durable and longer term data data it seems so far!  IMHO


Eoganacht wrote: Yes it looks like 34.9% CRR at 12 months. And this is down to 20% CRR at 21 months !

Here is a link to their presentation:

Pivotal Results from BOND-003

The results and swimmers plot are on slide 8.

6   month DOR  = 52 out of 97 patients = 54%
12 month DOR  = 29 out of 83 patients= 34.9%
21 months DOR = 14 out of 69 patients = 20%


enriquesuave wrote: Looks like they just presented data and from what I understand 29 out of 83 patients have maintained.  They treated 105 patients and 75% have achieved a CR at anytime.  22 patients are still pending data at 12 months.  So 29 out of 83 so far = 34.9% CR at 12 months. Seems like we are beating them badly. IMHO time will tell .  Will we hit $4 USD Billion MC like them when we get BTD?



 

<< Previous
Bullboard Posts
Next >>